上海微创心脉医疗科技（集团）股份有限公司关于选举第三届董事会职工代表董事的公告

Core Points - The company held its first extraordinary general meeting of shareholders on November 14, 2025, where it approved the cancellation of the supervisory board and the amendment of the company's articles of association [1][4] - The company elected Yuan Zhenyu as the employee representative director for the third board of directors, with his term starting from the approval date of the election [1][2] Group 1: Shareholder Meeting Details - The extraordinary general meeting was held on November 14, 2025, at the company's meeting room in Shanghai [5] - The meeting was conducted with both on-site and online voting, presided over by the chairman, Jonathan Chen, and complied with relevant laws and regulations [5][6] - All current directors and supervisors attended the meeting, ensuring a quorum [5] Group 2: Resolutions Passed - The following resolutions were approved during the meeting: 1. Cancellation of the supervisory board and amendment of the articles of association [6] 2. Revision and addition of certain management systems [6] 3. Purchase of liability insurance for directors and senior management [6][7] - The first resolution required a two-thirds majority to pass, while the other resolutions were approved by a simple majority [7] Group 3: Election of Employee Representative Director - Yuan Zhenyu was elected as the employee representative director, meeting all legal and regulatory requirements [2][3] - His background includes a Ph.D. from Shanghai Jiao Tong University and extensive experience in the company since 2007 [3]